Morgan Stanley Sonendo, Inc. Transaction History

Morgan Stanley

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$0.75 - $1.4 $1,359 - $2,536	1,812 Added 1.07%	170,960 $128,000
Q2 2023 Aug 14, 2023	BUY	$1.06 - $2.01 $24,350 - $46,173	22,972 Added 15.72%	169,148 $230,000
Q1 2023 May 15, 2023	BUY	$1.53 - $2.71 $2,435 - $4,314	1,592 Added 1.1%	146,176 $292,000
Q4 2022 Feb 14, 2023	BUY	$1.11 - $2.9 $1,545 - $4,036	1,392 Added 0.97%	144,584 $409,000
Q3 2022 Nov 14, 2022	SELL	$0.91 - $2.09 $4,505 - $10,347	-4,951 Reduced 3.34%	143,192 $153,000
Q2 2022 Oct 27, 2022	BUY	$1.72 - $3.73 $254,754 - $552,461	148,113 Added 493710.0%	148,143 $255,000
Q2 2022 Aug 15, 2022	BUY	$1.72 - $3.73 $254,754 - $552,461	148,113 Added 493710.0%	148,143 $255,000
Q1 2022 Oct 27, 2022	SELL	$3.12 - $8.17 $462,112 - $1.21 Million	-148,113 Reduced 99.98%	30 $0
Q1 2022 May 13, 2022	SELL	$3.12 - $8.17 $218 - $571	-70 Reduced 70.0%	30 $0
Q4 2021 Feb 14, 2022	BUY	$5.72 - $11.56 $572 - $1,156	100 New	100 $1,000

7.78M

Ticker SONX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,661,200
Market Cap $105M
Description
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company a...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.